Prescription medicine
Halcinonide Brand names: Halog
Halcinonide (Halog) is a prescription medicine with an FDA approval on record since 1974. FDA's NDC Directory lists it from 2 generic labelers, and pharmacies paid $6.08 per mL (Halcinonide 0.1% solution) in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the halcinonide FDA label on DailyMed (effective October 15, 2025, Sun Pharmaceutical Industries, Inc.); the NDA 17556 record on Drugs@FDA; every halcinonide label on DailyMed.
Highlights of the record
FDA label of October 15, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageHalcinonide cream, USP, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Forms and strengths
- 1 mg/g
- 1 mg/ml
Cream; solution.
On the market
- Earliest approval on file
- November 27, 1974 Halog, Sun Pharm Inds Inc; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 3 first August 12, 2019; 3 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 5 of which 2 under generic applications, 3 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $6.08 per mL Halcinonide 0.1% solution
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 193 through July 30, 2026
What is halcinonide used for?
From the label: indications and usageHalcinonide cream, USP, 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
FDA pharmacologic class: Corticosteroid.
Source: FDA drug label (HALCINONIDE), Sun Pharmaceutical Industries, Inc., effective October 15, 2025 (SPL set aed461bb-e49e-44c4-b42f-b5b261c072a0), via openFDA; the full label on DailyMed
Is there a generic for halcinonide (Halog)?
The FDA approved the first generic halcinonide on August 12, 2019. 3 generic applications are approved; 3 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists halcinonide from 2 labelers under a generic (ANDA) application and from 3 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1974 earliest approval on file
- 2019 first generic approved
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for halcinonide (Halog)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $6.08 per mL (Halcinonide 0.1% solution). The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Halcinonide 0.1% solution (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Halcinonide 0.1% solution | Generic | $6.08 per mL | n/a | n/a |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What do FAERS reports show for halcinonide?
The FDA Adverse Event Reporting System holds 193 reports that list halcinonide among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 8 are coded as a death and 31 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other corticosteroids
- the pharmacologic class, with prices and generics
- Halcinonide side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other